3i Group plc (III.L) — Company Research
Last Updated: 11 June 2026
3i Group plc is an investment company that invests its own balance-sheet capital in private equity and infrastructure. Its defining position is a 65.4% stake in Action, the Dutch-headquartered European non-food discount retailer, valued at £23.7 billion at 31 March 2026 — roughly three quarters of 3i’s net asset value. The FY2026 results (published 14 May 2026) delivered a 22% total return and a NAV of 3,030 pence per share, yet the shares have more than halved from their October 2025 peak as Action’s like-for-like sales growth slowed, swinging the stock from a long-standing premium to NAV to a wide discount and prompting 3i’s first buyback in two decades.
1. Company Snapshot
| Field | Value |
|---|---|
| Company | 3i Group plc |
| Ticker / Listing | LSE: III |
| Sector | Investment company — private equity and infrastructure (proprietary capital) |
| Revenue (FY2026 gross investment return) | £5,464m (value growth, dividends and interest from the portfolio, year to 31 March 2026) |
| Net income (FY2026 total return) | £5,304m total comprehensive income, a 22% return on opening shareholders’ funds |
| Net asset value | £30,887m, or 3,030p per share, at 31 March 2026 (31 March 2025: 2,542p) |
| CEO / Leadership | Simon Borrows, Chief Executive (since 2012) |
| Employees | ≈220 (one of the leanest teams among UK blue chips relative to assets) |
| Headquarters | London, UK |
| Founded | 1945 (as the Industrial and Commercial Finance Corporation) |
| Financial year end | 31 March |
2. Bull & Bear Case
Bull Case
- Action’s compounding machine: Action generated a gross investment return of £4,510m (25% on opening value) in FY2026, grew 2025 net sales 16% and EBITDA 14%, and retains a powerful multi-year store roll-out runway across Europe — with 69 new stores already opened in 2026 year to date and a planned US entry extending the white space.
- Consistent double-digit NAV compounding: total returns of 36% (FY2023), 23% (FY2024), 25% (FY2025) and 22% (FY2026) have compounded NAV per share from 1,745p to 3,030p in three years, comfortably above 3i’s 15% through-the-cycle target.
- Deep discount plus first buyback since 2005: at ≈2,187p the shares trade roughly 28% below the 3,030p NAV, and the board has responded with a £750m buyback to be completed before 31 December 2026 — buying assets at a discount with the CEO personally purchasing £1.1m of shares in May 2026.
- Conservative balance sheet and cash generation: gearing was just 2% at year end (net debt £547m), liquidity stood at £1,864m, and the group received £1.9bn of portfolio cash proceeds in FY2026, including realisations of MPM and MAIT at money multiples above the 2x target and Action dividends.
Bear Case
- Extreme single-asset concentration: Action represents about 74% of NAV, so 3i is effectively a leveraged bet on one discount retailer; any stumble in Action’s growth, margins or valuation multiple dominates everything else in the portfolio.
- Action’s like-for-like slowdown: year-to-date LFL sales growth was 2.4% at week 19 of 2026 against 6.8% a year earlier, with flat trading in France and Germany; the update triggered the sharpest one-day fall in 3i shares on record on results day.
- US expansion execution risk: investors reacted poorly in March 2026 to Action’s planned US entry, which brings currency, supply-chain and competitive risks (dollar stores, Walmart) outside Action’s proven European playbook.
3. Business Segments
3i invests proprietary capital — it does not primarily manage third-party funds. The split below uses the FY2026 gross investment return (GIR) of £5,464m as the revenue analogue.
| Segment | % of revenue | What it is |
|---|---|---|
| Private Equity | ≈97% (£5,303m GIR) | Controlling and significant minority stakes in mid-market and long-hold European companies. Dominated by the 65.4% stake in Action (£23,743m value; £4,510m GIR); also includes Royal Sanders, Basic-Fit (5.8% listed stake) and consumer, healthcare, industrial and services/software holdings. FY2026 realisations included MPM and MAIT (£542m proceeds). |
| Infrastructure | ≈2% (£106m GIR) | Principally a 29% stake in listed 3i Infrastructure plc (valued at £897m) plus management of infrastructure funds; 3iN realised its largest asset, TCR, for €1.1bn at a 3.6x money multiple during the year. |
| Scandlines | ≈1% (£55m GIR) | The Denmark–Germany ferry operator held as a stand-alone long-term asset; highly cash generative, paying 3i £21m of dividends in FY2026. |
4. Business Model & Moat
How it makes money. 3i invests its own permanent balance-sheet capital and earns returns through value growth, dividends and interest on portfolio companies — reported as gross investment return — plus fee income from managing 3i Infrastructure and related funds. Unlike conventional private equity firms it does not depend on raising external buyout funds, so it pays no carry away and faces no fundraising cycle; cash from realisations and portfolio dividends (£1.9bn in FY2026) is recycled into new investment, the dividend (84.5p for FY2026) and now a £750m buyback.
The moat. Permanent capital allows 3i to hold winners indefinitely — it has compounded Action since 2011 rather than selling it to crystallise carry, something fund-based rivals cannot easily replicate. The group runs with a famously lean team (≈220 staff), an operating cost base of £135m against a £31.8bn portfolio, and 2% gearing, making the model unusually scalable and the costs negligible relative to NAV.
Capital discipline. Investment is selective (£907m cash invested in FY2026, against £1,517m of realised proceeds); the dividend policy aims to maintain or grow the payout each year, and the new buyback adds a second return channel when the shares trade below NAV.
5. Financial Health
Figures below are from 3i’s audited results announcements for the years to 31 March (Investment basis). As an investment company 3i’s “revenue” is its gross investment return (GIR): realised and unrealised value movements plus portfolio income. Long-term debt is gross borrowings at year end.
| Year | Revenue (GIR, £m) | YoY % | GAAP EPS | Adjusted EPS | Dividend/share | Long-term debt (YE) |
|---|---|---|---|---|---|---|
| FY2023 | £5,104m | — | 475.0p | n/m (not reported) | 53.0p | £775m |
| FY2024 | £4,168m | -18.3% | 397.9p | n/m (not reported) | 61.0p | £1,202m |
| FY2025 | £5,211m | +25.0% | 522.0p | n/m (not reported) | 73.0p | £1,194m |
| FY2026 | £5,464m | +4.9% | 539.4p | n/m (not reported) | 84.5p | £1,211m |
The balance sheet remains conservative: net debt of £547m at 31 March 2026 (gearing 2% of net assets), liquidity of £1,864m and an operating cash profit of £276m (FY2025: £469m, the decline reflecting the timing of Action dividends — a further ≈£255m Action dividend was approved for receipt by the end of May 2026). Total dividends have grown from 53.0p to 84.5p in three years, a ≈17% compound rate.
3i reports half-yearly. The split of FY2026 is shown below (H2 derived as full year minus H1).
| Quarter / Half | Revenue (GIR, £m) | Adjusted EPS | GAAP EPS |
|---|---|---|---|
| H2 FY2026 (Oct 2025–Mar 2026) | £2,058m | n/m | 199.2p |
| H1 FY2026 (Apr–Sep 2025) | £3,406m | n/m | 340.2p |
| Full year (FY2026) | £5,464m | n/m | 539.4p |
6. Valuation Metrics
Share prices, and figures worked out from them, are not shown for London-listed companies on ChartsView. See the III price on TradingView
Raw metrics, June 2026. Not opinions on whether the stock is cheap or expensive.
| Metric | Value |
|---|---|
| Short interest (% of float) | ≈0% disclosed — no current or historic FCA-disclosable net short positions (≥0.5%) in 3i Group in the FCA daily short positions register at 10 June 2026 |
7. Growth Drivers
Action’s store roll-out. Action’s growth algorithm combines new stores (69 opened in 2026 year to date, with management citing significant remaining white space across Europe) with like-for-like growth and margin leverage; first-three-period 2026 net sales rose to €4,010m from €3,521m a year earlier with operating EBITDA of €498m.
US market entry. Action plans to enter the United States, a step-change in the addressable market for the format — high potential reward, though it is also a key execution risk the market is currently discounting.
Broader Private Equity portfolio. Royal Sanders delivered another year of robust growth, standout performers sit in the consumer and private-label sector, and realisations (MPM, MAIT at >2x money multiples) recycle capital into new platforms.
Buyback at a discount.
8. Peer Comparison
No listed peer shares 3i’s proprietary-capital, single-asset-heavy model; the closest comparators are listed European private-markets groups.
| Peer | Key 2025 metric |
|---|---|
| EQT AB (STO: EQT) | Total AUM of €270bn at end-2025 with fee-generating AUM of €141bn; gross inflows of €26bn, more than double 2024 |
| Partners Group (SWX: PGHN) | Record AuM of $185bn at 31 December 2025 (up from $152bn) with revenue up 20% in 2025 |
| Intermediate Capital Group (LSE: ICG) | AUM of ≈$127bn at 31 December 2025, up from ≈$123bn reported at FY2025 |
9. Insider Activity
| Name | Date | Type | Shares | Plan Type |
|---|---|---|---|---|
| Simon Borrows (CEO) | 21 May 2026 | Buy | 50,000 | Open-market purchase |
| Simon Borrows (CEO, incl. family trusts as PCAs) | 26 Mar 2026 | Buy | 350,147 (39,123 direct) | Open-market purchase |
10. Key Risks
- Action concentration: ≈74% of NAV sits in one private retailer; a sustained deterioration in Action’s growth or profitability, or a cut to the earnings multiple used in its valuation, would directly and materially reduce 3i’s NAV.
- European consumer weakness: Action’s 2026 LFL growth has slowed to 2.4% year to date, with flat performance in France and Germany amid consumer caution and the fallout from the Middle East conflict; cooler weather has also hurt seasonal categories.
- US expansion execution: entering the US exposes Action to entrenched discount competitors, different supply chains and tariff/geopolitical frictions, with the investment phase likely to weigh on near-term cash generation.
- Key-person and team risk: an unusually small team and a long-tenured CEO (since 2012) concentrate decision-making; succession or departures could unsettle the investment approach.
11. Recent Developments
- 21 May 2026 — CEO buys £1.1m of shares. Simon Borrows purchased 50,000 shares at £22.2863 on the London Stock Exchange, his second significant purchase of 2026, after the post-results sell-off.
- 14 May 2026 — FY2026 results: strong NAV growth, but shares plunge on Action slowdown. 3i reported a 22% total return, NAV of 3,030p (+19%) and a total dividend of 84.5p (+16%), and announced a £750m buyback — its first since 2005. The shares nonetheless fell by double digits on the day as Action’s week-19 year-to-date LFL growth of 2.4% (vs 6.8% a year earlier) disappointed, leaving the stock at a wide discount to NAV.
- 26 Mar 2026 — CEO and family trusts buy 350,147 shares. Simon Borrows and associated family trusts bought ≈£8.9m of stock at £25.55 following the March sell-off that accompanied Action’s US-entry announcement and capital markets seminar.
12. Key Dates
- 18 Jun 2026 — ex-dividend date for the second FY2026 dividend of 48.0p per share (record date 19 June 2026)
- 23 Jul 2026 — Q1 FY2027 performance update (per 3i’s financial calendar)
- 24 Jul 2026 — payment of the second FY2026 dividend of 48.0p, subject to shareholder approval at the AGM
- Expected Nov 2026 — half-year FY2027 results (the FY2026 half-year results were released on 13 November 2025)
- 31 Dec 2026 — targeted completion date for the £750m share buyback programme
Macro events relevant to a consumer-exposed portfolio — eurozone inflation prints, ECB decisions and retail sales data — can be tracked on our Economic Calendar, and you can discuss 3i Group with other investors on the ChartsView Forum.
Disclaimer: This research is produced by ChartsView for educational and informational purposes only. It does not constitute financial advice or a recommendation to buy or sell any security. All information is sourced from publicly available company filings, press releases, and official data. ChartsView does not use analyst opinions or third-party ratings. Always conduct your own due diligence and consider your personal financial situation before making investment decisions. Past performance is not indicative of future results.
Loading research report…
13. Thesis Verdict
The central thesis. 3i Group invests its own permanent capital in private equity and infrastructure, earning returns through portfolio value growth, dividends and interest — dominated by its 65.4% stake in European discount retailer Action, valued at £23.7bn and roughly 74% of NAV. FY2026 (to 31 March 2026) produced a 22% total return, NAV per share of 3,030p (+19%), a gross investment return of £5,464m and a dividend raised 16% to 84.5p, and management announced a £750m buyback — its first since 2005 — to be completed by 31 December 2026. The structural driver remains Action’s store roll-out and like-for-like compounding, now extended by a planned US market entry.
What would confirm or break it. Confirmation would come from Action’s like-for-like sales growth re-accelerating from the 2.4% year-to-date pace reported in May 2026, buyback execution narrowing the discount to NAV, and continued realisations above carrying value. The thesis would break if Action’s slowdown in France and Germany persisted or deepened, if 3i’s private valuation of Action were cut, or if the US expansion misfired — any of which would strike at the asset that constitutes three quarters of NAV.
Watchpoints
- ConfirmsQ1 FY2027 performance update (23 July 2026) (42 days) landing in line with or above management guidance.
- ConfirmsEvidence supporting the "Action’s compounding machine:" thesis continuing to build across subsequent filings.
- InvalidatesMaterialisation of the "Action concentration:" risk, or any disclosure that fundamentally alters the capital-return or growth profile stated by management.
Diagnostic grid
Generated by ChartsView research tooling. Thesis strength measures how well the evidence in this report supports the company's stated thesis — it is NOT a buy/sell rating or price target. ChartsView is not authorised by the FCA to provide regulated investment advice. Generated 11 Jun 2026.